{"id":"W2166360124","doi":"10.1056/nejmoa067594","title":"Certolizumab Pegol for the Treatment of Crohn's Disease","year":2007,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1140,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University","funders":"National Center for Research Resources; Towson University; University of South Carolina; University of Louisville","keywords":"Certolizumab pegol; Medicine; Placebo; Crohn's disease; Internal medicine; Randomized controlled trial; Gastroenterology; Disease; Adalimumab; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009272909,0.0003685248,0.001007107,0.0002555899,0.0001653309,0.0003179762,0.0002427415,0.0006678505,0.002342058],"category_scores_gemma":[0.0006598671,0.0001254454,0.0005208915,0.0002436753,0.0003467228,0.0001857137,0.0001698776,0.001034468,0.0004086001],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002084609,"about_ca_system_score_gemma":0.0003001456,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001970529,"about_ca_topic_score_gemma":0.0003665345,"domain_scores_codex":[0.9997622,0.0001227024,0.00002687456,0.00002830428,0.00003619469,0.00002372198],"domain_scores_gemma":[0.9996827,0.0001132707,0.0001064643,0.000009932503,0.00002004248,0.00006770773],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2826064,0.005880046,0.01300257,0.009661304,0.002086983,0.001024708,0.0001555518,0.001515693,0.03622053,0.000701414,0.008382734,0.6387621],"study_design_scores_gemma":[0.6927363,0.1905657,0.04273762,0.001910789,0.002958252,0.00458633,0.0001423638,0.002113752,0.01012391,0.0009422326,0.05113224,0.00005058229],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6268966,0.3600774,0.001139774,0.005726564,0.001349507,0.0009111505,0.0003980211,0.00009790047,0.003403],"genre_scores_gemma":[0.9115798,0.07947396,0.002383244,0.002598458,0.001331161,0.0005094396,0.0005732613,0.00001034393,0.001540218],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002342058,"threshold_uncertainty_score":0.007834911,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01326523126089393,"score_gpt":0.2802427581146855,"score_spread":0.2669775268537916,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}